Global Biosimilar Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biosimilar Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.
The Global Info Research report includes an overview of the development of the Biosimilar Drug industry chain, the market status of Ankylosing Spondylitis (Injection, Tablets), Tumor (Injection, Tablets), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilar Drug.
Regionally, the report analyzes the Biosimilar Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilar Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilar Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilar Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Injection, Tablets).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilar Drug market.
Regional Analysis: The report involves examining the Biosimilar Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilar Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilar Drug:
Company Analysis: Report covers individual Biosimilar Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilar Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Ankylosing Spondylitis, Tumor).
Technology Analysis: Report covers specific technologies relevant to Biosimilar Drug. It assesses the current state, advancements, and potential future developments in Biosimilar Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilar Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilar Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Biosimilar Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biosimilar Drug, with price, sales, revenue and global market share of Biosimilar Drug from 2019 to 2024.
Chapter 3, the Biosimilar Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biosimilar Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biosimilar Drug.
Chapter 14 and 15, to describe Biosimilar Drug sales channel, distributors, customers, research findings and conclusion.
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.
East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.
In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.
The Global Info Research report includes an overview of the development of the Biosimilar Drug industry chain, the market status of Ankylosing Spondylitis (Injection, Tablets), Tumor (Injection, Tablets), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biosimilar Drug.
Regionally, the report analyzes the Biosimilar Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biosimilar Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biosimilar Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biosimilar Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Injection, Tablets).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biosimilar Drug market.
Regional Analysis: The report involves examining the Biosimilar Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biosimilar Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biosimilar Drug:
Company Analysis: Report covers individual Biosimilar Drug manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biosimilar Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Ankylosing Spondylitis, Tumor).
Technology Analysis: Report covers specific technologies relevant to Biosimilar Drug. It assesses the current state, advancements, and potential future developments in Biosimilar Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biosimilar Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biosimilar Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Injection
- Tablets
- Other Types
- Ankylosing Spondylitis
- Tumor
- Rheumatoid Arthrtis
- Cardiovascular
- Other Application
- CP Guojian Pharma
- Biotech Pharma
- Celgen Pharma
- Henlius
- Amgen
- Eli Lilly
- Sandoz
- Changchun High Tech
- Innovent
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Biosimilar Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biosimilar Drug, with price, sales, revenue and global market share of Biosimilar Drug from 2019 to 2024.
Chapter 3, the Biosimilar Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biosimilar Drug market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biosimilar Drug.
Chapter 14 and 15, to describe Biosimilar Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biosimilar Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Injection
1.3.3 Tablets
1.3.4 Other Types
1.4 Market Analysis by Application
1.4.1 Overview: Global Biosimilar Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Ankylosing Spondylitis
1.4.3 Tumor
1.4.4 Rheumatoid Arthrtis
1.4.5 Cardiovascular
1.4.6 Other Application
1.5 Global Biosimilar Drug Market Size & Forecast
1.5.1 Global Biosimilar Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biosimilar Drug Sales Quantity (2019-2030)
1.5.3 Global Biosimilar Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 CP Guojian Pharma
2.1.1 CP Guojian Pharma Details
2.1.2 CP Guojian Pharma Major Business
2.1.3 CP Guojian Pharma Biosimilar Drug Product and Services
2.1.4 CP Guojian Pharma Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CP Guojian Pharma Recent Developments/Updates
2.2 Biotech Pharma
2.2.1 Biotech Pharma Details
2.2.2 Biotech Pharma Major Business
2.2.3 Biotech Pharma Biosimilar Drug Product and Services
2.2.4 Biotech Pharma Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biotech Pharma Recent Developments/Updates
2.3 Celgen Pharma
2.3.1 Celgen Pharma Details
2.3.2 Celgen Pharma Major Business
2.3.3 Celgen Pharma Biosimilar Drug Product and Services
2.3.4 Celgen Pharma Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgen Pharma Recent Developments/Updates
2.4 Henlius
2.4.1 Henlius Details
2.4.2 Henlius Major Business
2.4.3 Henlius Biosimilar Drug Product and Services
2.4.4 Henlius Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Henlius Recent Developments/Updates
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Biosimilar Drug Product and Services
2.5.4 Amgen Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Amgen Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Biosimilar Drug Product and Services
2.6.4 Eli Lilly Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eli Lilly Recent Developments/Updates
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Biosimilar Drug Product and Services
2.7.4 Sandoz Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sandoz Recent Developments/Updates
2.8 Changchun High Tech
2.8.1 Changchun High Tech Details
2.8.2 Changchun High Tech Major Business
2.8.3 Changchun High Tech Biosimilar Drug Product and Services
2.8.4 Changchun High Tech Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Changchun High Tech Recent Developments/Updates
2.9 Innovent
2.9.1 Innovent Details
2.9.2 Innovent Major Business
2.9.3 Innovent Biosimilar Drug Product and Services
2.9.4 Innovent Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Innovent Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOSIMILAR DRUG BY MANUFACTURER
3.1 Global Biosimilar Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biosimilar Drug Revenue by Manufacturer (2019-2024)
3.3 Global Biosimilar Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biosimilar Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biosimilar Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Biosimilar Drug Manufacturer Market Share in 2023
3.5 Biosimilar Drug Market: Overall Company Footprint Analysis
3.5.1 Biosimilar Drug Market: Region Footprint
3.5.2 Biosimilar Drug Market: Company Product Type Footprint
3.5.3 Biosimilar Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biosimilar Drug Market Size by Region
4.1.1 Global Biosimilar Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Biosimilar Drug Consumption Value by Region (2019-2030)
4.1.3 Global Biosimilar Drug Average Price by Region (2019-2030)
4.2 North America Biosimilar Drug Consumption Value (2019-2030)
4.3 Europe Biosimilar Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Biosimilar Drug Consumption Value (2019-2030)
4.5 South America Biosimilar Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Biosimilar Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biosimilar Drug Sales Quantity by Type (2019-2030)
5.2 Global Biosimilar Drug Consumption Value by Type (2019-2030)
5.3 Global Biosimilar Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biosimilar Drug Sales Quantity by Application (2019-2030)
6.2 Global Biosimilar Drug Consumption Value by Application (2019-2030)
6.3 Global Biosimilar Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biosimilar Drug Sales Quantity by Type (2019-2030)
7.2 North America Biosimilar Drug Sales Quantity by Application (2019-2030)
7.3 North America Biosimilar Drug Market Size by Country
7.3.1 North America Biosimilar Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Biosimilar Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biosimilar Drug Sales Quantity by Type (2019-2030)
8.2 Europe Biosimilar Drug Sales Quantity by Application (2019-2030)
8.3 Europe Biosimilar Drug Market Size by Country
8.3.1 Europe Biosimilar Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Biosimilar Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biosimilar Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biosimilar Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biosimilar Drug Market Size by Region
9.3.1 Asia-Pacific Biosimilar Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biosimilar Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biosimilar Drug Sales Quantity by Type (2019-2030)
10.2 South America Biosimilar Drug Sales Quantity by Application (2019-2030)
10.3 South America Biosimilar Drug Market Size by Country
10.3.1 South America Biosimilar Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Biosimilar Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biosimilar Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biosimilar Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biosimilar Drug Market Size by Country
11.3.1 Middle East & Africa Biosimilar Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biosimilar Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biosimilar Drug Market Drivers
12.2 Biosimilar Drug Market Restraints
12.3 Biosimilar Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biosimilar Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biosimilar Drug
13.3 Biosimilar Drug Production Process
13.4 Biosimilar Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biosimilar Drug Typical Distributors
14.3 Biosimilar Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biosimilar Drug Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Injection
1.3.3 Tablets
1.3.4 Other Types
1.4 Market Analysis by Application
1.4.1 Overview: Global Biosimilar Drug Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Ankylosing Spondylitis
1.4.3 Tumor
1.4.4 Rheumatoid Arthrtis
1.4.5 Cardiovascular
1.4.6 Other Application
1.5 Global Biosimilar Drug Market Size & Forecast
1.5.1 Global Biosimilar Drug Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biosimilar Drug Sales Quantity (2019-2030)
1.5.3 Global Biosimilar Drug Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 CP Guojian Pharma
2.1.1 CP Guojian Pharma Details
2.1.2 CP Guojian Pharma Major Business
2.1.3 CP Guojian Pharma Biosimilar Drug Product and Services
2.1.4 CP Guojian Pharma Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 CP Guojian Pharma Recent Developments/Updates
2.2 Biotech Pharma
2.2.1 Biotech Pharma Details
2.2.2 Biotech Pharma Major Business
2.2.3 Biotech Pharma Biosimilar Drug Product and Services
2.2.4 Biotech Pharma Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Biotech Pharma Recent Developments/Updates
2.3 Celgen Pharma
2.3.1 Celgen Pharma Details
2.3.2 Celgen Pharma Major Business
2.3.3 Celgen Pharma Biosimilar Drug Product and Services
2.3.4 Celgen Pharma Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgen Pharma Recent Developments/Updates
2.4 Henlius
2.4.1 Henlius Details
2.4.2 Henlius Major Business
2.4.3 Henlius Biosimilar Drug Product and Services
2.4.4 Henlius Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Henlius Recent Developments/Updates
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Biosimilar Drug Product and Services
2.5.4 Amgen Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Amgen Recent Developments/Updates
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business
2.6.3 Eli Lilly Biosimilar Drug Product and Services
2.6.4 Eli Lilly Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eli Lilly Recent Developments/Updates
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Biosimilar Drug Product and Services
2.7.4 Sandoz Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sandoz Recent Developments/Updates
2.8 Changchun High Tech
2.8.1 Changchun High Tech Details
2.8.2 Changchun High Tech Major Business
2.8.3 Changchun High Tech Biosimilar Drug Product and Services
2.8.4 Changchun High Tech Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Changchun High Tech Recent Developments/Updates
2.9 Innovent
2.9.1 Innovent Details
2.9.2 Innovent Major Business
2.9.3 Innovent Biosimilar Drug Product and Services
2.9.4 Innovent Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Innovent Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOSIMILAR DRUG BY MANUFACTURER
3.1 Global Biosimilar Drug Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biosimilar Drug Revenue by Manufacturer (2019-2024)
3.3 Global Biosimilar Drug Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biosimilar Drug by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biosimilar Drug Manufacturer Market Share in 2023
3.4.2 Top 6 Biosimilar Drug Manufacturer Market Share in 2023
3.5 Biosimilar Drug Market: Overall Company Footprint Analysis
3.5.1 Biosimilar Drug Market: Region Footprint
3.5.2 Biosimilar Drug Market: Company Product Type Footprint
3.5.3 Biosimilar Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biosimilar Drug Market Size by Region
4.1.1 Global Biosimilar Drug Sales Quantity by Region (2019-2030)
4.1.2 Global Biosimilar Drug Consumption Value by Region (2019-2030)
4.1.3 Global Biosimilar Drug Average Price by Region (2019-2030)
4.2 North America Biosimilar Drug Consumption Value (2019-2030)
4.3 Europe Biosimilar Drug Consumption Value (2019-2030)
4.4 Asia-Pacific Biosimilar Drug Consumption Value (2019-2030)
4.5 South America Biosimilar Drug Consumption Value (2019-2030)
4.6 Middle East and Africa Biosimilar Drug Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biosimilar Drug Sales Quantity by Type (2019-2030)
5.2 Global Biosimilar Drug Consumption Value by Type (2019-2030)
5.3 Global Biosimilar Drug Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biosimilar Drug Sales Quantity by Application (2019-2030)
6.2 Global Biosimilar Drug Consumption Value by Application (2019-2030)
6.3 Global Biosimilar Drug Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biosimilar Drug Sales Quantity by Type (2019-2030)
7.2 North America Biosimilar Drug Sales Quantity by Application (2019-2030)
7.3 North America Biosimilar Drug Market Size by Country
7.3.1 North America Biosimilar Drug Sales Quantity by Country (2019-2030)
7.3.2 North America Biosimilar Drug Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biosimilar Drug Sales Quantity by Type (2019-2030)
8.2 Europe Biosimilar Drug Sales Quantity by Application (2019-2030)
8.3 Europe Biosimilar Drug Market Size by Country
8.3.1 Europe Biosimilar Drug Sales Quantity by Country (2019-2030)
8.3.2 Europe Biosimilar Drug Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biosimilar Drug Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biosimilar Drug Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biosimilar Drug Market Size by Region
9.3.1 Asia-Pacific Biosimilar Drug Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biosimilar Drug Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biosimilar Drug Sales Quantity by Type (2019-2030)
10.2 South America Biosimilar Drug Sales Quantity by Application (2019-2030)
10.3 South America Biosimilar Drug Market Size by Country
10.3.1 South America Biosimilar Drug Sales Quantity by Country (2019-2030)
10.3.2 South America Biosimilar Drug Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biosimilar Drug Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biosimilar Drug Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biosimilar Drug Market Size by Country
11.3.1 Middle East & Africa Biosimilar Drug Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biosimilar Drug Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biosimilar Drug Market Drivers
12.2 Biosimilar Drug Market Restraints
12.3 Biosimilar Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biosimilar Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biosimilar Drug
13.3 Biosimilar Drug Production Process
13.4 Biosimilar Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biosimilar Drug Typical Distributors
14.3 Biosimilar Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Biosimilar Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilar Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CP Guojian Pharma Basic Information, Manufacturing Base and Competitors
Table 4. CP Guojian Pharma Major Business
Table 5. CP Guojian Pharma Biosimilar Drug Product and Services
Table 6. CP Guojian Pharma Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CP Guojian Pharma Recent Developments/Updates
Table 8. Biotech Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Biotech Pharma Major Business
Table 10. Biotech Pharma Biosimilar Drug Product and Services
Table 11. Biotech Pharma Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biotech Pharma Recent Developments/Updates
Table 13. Celgen Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Celgen Pharma Major Business
Table 15. Celgen Pharma Biosimilar Drug Product and Services
Table 16. Celgen Pharma Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Celgen Pharma Recent Developments/Updates
Table 18. Henlius Basic Information, Manufacturing Base and Competitors
Table 19. Henlius Major Business
Table 20. Henlius Biosimilar Drug Product and Services
Table 21. Henlius Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Henlius Recent Developments/Updates
Table 23. Amgen Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Major Business
Table 25. Amgen Biosimilar Drug Product and Services
Table 26. Amgen Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Amgen Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly Biosimilar Drug Product and Services
Table 31. Eli Lilly Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. Sandoz Basic Information, Manufacturing Base and Competitors
Table 34. Sandoz Major Business
Table 35. Sandoz Biosimilar Drug Product and Services
Table 36. Sandoz Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sandoz Recent Developments/Updates
Table 38. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 39. Changchun High Tech Major Business
Table 40. Changchun High Tech Biosimilar Drug Product and Services
Table 41. Changchun High Tech Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Changchun High Tech Recent Developments/Updates
Table 43. Innovent Basic Information, Manufacturing Base and Competitors
Table 44. Innovent Major Business
Table 45. Innovent Biosimilar Drug Product and Services
Table 46. Innovent Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Innovent Recent Developments/Updates
Table 48. Global Biosimilar Drug Sales Quantity by Manufacturer (2019-2024) & (K Dose)
Table 49. Global Biosimilar Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Biosimilar Drug Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 51. Market Position of Manufacturers in Biosimilar Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Biosimilar Drug Production Site of Key Manufacturer
Table 53. Biosimilar Drug Market: Company Product Type Footprint
Table 54. Biosimilar Drug Market: Company Product Application Footprint
Table 55. Biosimilar Drug New Market Entrants and Barriers to Market Entry
Table 56. Biosimilar Drug Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Biosimilar Drug Sales Quantity by Region (2019-2024) & (K Dose)
Table 58. Global Biosimilar Drug Sales Quantity by Region (2025-2030) & (K Dose)
Table 59. Global Biosimilar Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Biosimilar Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Biosimilar Drug Average Price by Region (2019-2024) & (USD/Dose)
Table 62. Global Biosimilar Drug Average Price by Region (2025-2030) & (USD/Dose)
Table 63. Global Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 64. Global Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 65. Global Biosimilar Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Biosimilar Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Biosimilar Drug Average Price by Type (2019-2024) & (USD/Dose)
Table 68. Global Biosimilar Drug Average Price by Type (2025-2030) & (USD/Dose)
Table 69. Global Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 70. Global Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 71. Global Biosimilar Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Biosimilar Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Biosimilar Drug Average Price by Application (2019-2024) & (USD/Dose)
Table 74. Global Biosimilar Drug Average Price by Application (2025-2030) & (USD/Dose)
Table 75. North America Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 76. North America Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 77. North America Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 78. North America Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 79. North America Biosimilar Drug Sales Quantity by Country (2019-2024) & (K Dose)
Table 80. North America Biosimilar Drug Sales Quantity by Country (2025-2030) & (K Dose)
Table 81. North America Biosimilar Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Biosimilar Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 84. Europe Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 85. Europe Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 86. Europe Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 87. Europe Biosimilar Drug Sales Quantity by Country (2019-2024) & (K Dose)
Table 88. Europe Biosimilar Drug Sales Quantity by Country (2025-2030) & (K Dose)
Table 89. Europe Biosimilar Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Biosimilar Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 92. Asia-Pacific Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 93. Asia-Pacific Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 94. Asia-Pacific Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 95. Asia-Pacific Biosimilar Drug Sales Quantity by Region (2019-2024) & (K Dose)
Table 96. Asia-Pacific Biosimilar Drug Sales Quantity by Region (2025-2030) & (K Dose)
Table 97. Asia-Pacific Biosimilar Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Biosimilar Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 100. South America Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 101. South America Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 102. South America Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 103. South America Biosimilar Drug Sales Quantity by Country (2019-2024) & (K Dose)
Table 104. South America Biosimilar Drug Sales Quantity by Country (2025-2030) & (K Dose)
Table 105. South America Biosimilar Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Biosimilar Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 108. Middle East & Africa Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 109. Middle East & Africa Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 110. Middle East & Africa Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 111. Middle East & Africa Biosimilar Drug Sales Quantity by Region (2019-2024) & (K Dose)
Table 112. Middle East & Africa Biosimilar Drug Sales Quantity by Region (2025-2030) & (K Dose)
Table 113. Middle East & Africa Biosimilar Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Biosimilar Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Biosimilar Drug Raw Material
Table 116. Key Manufacturers of Biosimilar Drug Raw Materials
Table 117. Biosimilar Drug Typical Distributors
Table 118. Biosimilar Drug Typical Customers
Table 1. Global Biosimilar Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biosimilar Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. CP Guojian Pharma Basic Information, Manufacturing Base and Competitors
Table 4. CP Guojian Pharma Major Business
Table 5. CP Guojian Pharma Biosimilar Drug Product and Services
Table 6. CP Guojian Pharma Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. CP Guojian Pharma Recent Developments/Updates
Table 8. Biotech Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Biotech Pharma Major Business
Table 10. Biotech Pharma Biosimilar Drug Product and Services
Table 11. Biotech Pharma Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Biotech Pharma Recent Developments/Updates
Table 13. Celgen Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Celgen Pharma Major Business
Table 15. Celgen Pharma Biosimilar Drug Product and Services
Table 16. Celgen Pharma Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Celgen Pharma Recent Developments/Updates
Table 18. Henlius Basic Information, Manufacturing Base and Competitors
Table 19. Henlius Major Business
Table 20. Henlius Biosimilar Drug Product and Services
Table 21. Henlius Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Henlius Recent Developments/Updates
Table 23. Amgen Basic Information, Manufacturing Base and Competitors
Table 24. Amgen Major Business
Table 25. Amgen Biosimilar Drug Product and Services
Table 26. Amgen Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Amgen Recent Developments/Updates
Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 29. Eli Lilly Major Business
Table 30. Eli Lilly Biosimilar Drug Product and Services
Table 31. Eli Lilly Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Eli Lilly Recent Developments/Updates
Table 33. Sandoz Basic Information, Manufacturing Base and Competitors
Table 34. Sandoz Major Business
Table 35. Sandoz Biosimilar Drug Product and Services
Table 36. Sandoz Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Sandoz Recent Developments/Updates
Table 38. Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table 39. Changchun High Tech Major Business
Table 40. Changchun High Tech Biosimilar Drug Product and Services
Table 41. Changchun High Tech Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Changchun High Tech Recent Developments/Updates
Table 43. Innovent Basic Information, Manufacturing Base and Competitors
Table 44. Innovent Major Business
Table 45. Innovent Biosimilar Drug Product and Services
Table 46. Innovent Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Innovent Recent Developments/Updates
Table 48. Global Biosimilar Drug Sales Quantity by Manufacturer (2019-2024) & (K Dose)
Table 49. Global Biosimilar Drug Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Biosimilar Drug Average Price by Manufacturer (2019-2024) & (USD/Dose)
Table 51. Market Position of Manufacturers in Biosimilar Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Biosimilar Drug Production Site of Key Manufacturer
Table 53. Biosimilar Drug Market: Company Product Type Footprint
Table 54. Biosimilar Drug Market: Company Product Application Footprint
Table 55. Biosimilar Drug New Market Entrants and Barriers to Market Entry
Table 56. Biosimilar Drug Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Biosimilar Drug Sales Quantity by Region (2019-2024) & (K Dose)
Table 58. Global Biosimilar Drug Sales Quantity by Region (2025-2030) & (K Dose)
Table 59. Global Biosimilar Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Biosimilar Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Biosimilar Drug Average Price by Region (2019-2024) & (USD/Dose)
Table 62. Global Biosimilar Drug Average Price by Region (2025-2030) & (USD/Dose)
Table 63. Global Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 64. Global Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 65. Global Biosimilar Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Biosimilar Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Biosimilar Drug Average Price by Type (2019-2024) & (USD/Dose)
Table 68. Global Biosimilar Drug Average Price by Type (2025-2030) & (USD/Dose)
Table 69. Global Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 70. Global Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 71. Global Biosimilar Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Biosimilar Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Biosimilar Drug Average Price by Application (2019-2024) & (USD/Dose)
Table 74. Global Biosimilar Drug Average Price by Application (2025-2030) & (USD/Dose)
Table 75. North America Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 76. North America Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 77. North America Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 78. North America Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 79. North America Biosimilar Drug Sales Quantity by Country (2019-2024) & (K Dose)
Table 80. North America Biosimilar Drug Sales Quantity by Country (2025-2030) & (K Dose)
Table 81. North America Biosimilar Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Biosimilar Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 84. Europe Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 85. Europe Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 86. Europe Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 87. Europe Biosimilar Drug Sales Quantity by Country (2019-2024) & (K Dose)
Table 88. Europe Biosimilar Drug Sales Quantity by Country (2025-2030) & (K Dose)
Table 89. Europe Biosimilar Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Biosimilar Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 92. Asia-Pacific Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 93. Asia-Pacific Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 94. Asia-Pacific Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 95. Asia-Pacific Biosimilar Drug Sales Quantity by Region (2019-2024) & (K Dose)
Table 96. Asia-Pacific Biosimilar Drug Sales Quantity by Region (2025-2030) & (K Dose)
Table 97. Asia-Pacific Biosimilar Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Biosimilar Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 100. South America Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 101. South America Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 102. South America Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 103. South America Biosimilar Drug Sales Quantity by Country (2019-2024) & (K Dose)
Table 104. South America Biosimilar Drug Sales Quantity by Country (2025-2030) & (K Dose)
Table 105. South America Biosimilar Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Biosimilar Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Biosimilar Drug Sales Quantity by Type (2019-2024) & (K Dose)
Table 108. Middle East & Africa Biosimilar Drug Sales Quantity by Type (2025-2030) & (K Dose)
Table 109. Middle East & Africa Biosimilar Drug Sales Quantity by Application (2019-2024) & (K Dose)
Table 110. Middle East & Africa Biosimilar Drug Sales Quantity by Application (2025-2030) & (K Dose)
Table 111. Middle East & Africa Biosimilar Drug Sales Quantity by Region (2019-2024) & (K Dose)
Table 112. Middle East & Africa Biosimilar Drug Sales Quantity by Region (2025-2030) & (K Dose)
Table 113. Middle East & Africa Biosimilar Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Biosimilar Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Biosimilar Drug Raw Material
Table 116. Key Manufacturers of Biosimilar Drug Raw Materials
Table 117. Biosimilar Drug Typical Distributors
Table 118. Biosimilar Drug Typical Customers
LIST OF FIGURES
Figure 1. Biosimilar Drug Picture
Figure 2. Global Biosimilar Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilar Drug Consumption Value Market Share by Type in 2023
Figure 4. Injection Examples
Figure 5. Tablets Examples
Figure 6. Other Types Examples
Figure 7. Global Biosimilar Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Biosimilar Drug Consumption Value Market Share by Application in 2023
Figure 9. Ankylosing Spondylitis Examples
Figure 10. Tumor Examples
Figure 11. Rheumatoid Arthrtis Examples
Figure 12. Cardiovascular Examples
Figure 13. Other Application Examples
Figure 14. Global Biosimilar Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Biosimilar Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Biosimilar Drug Sales Quantity (2019-2030) & (K Dose)
Figure 17. Global Biosimilar Drug Average Price (2019-2030) & (USD/Dose)
Figure 18. Global Biosimilar Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Biosimilar Drug Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Biosimilar Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Biosimilar Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Biosimilar Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Biosimilar Drug Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Biosimilar Drug Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Biosimilar Drug Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Biosimilar Drug Average Price by Type (2019-2030) & (USD/Dose)
Figure 33. Global Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Biosimilar Drug Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Biosimilar Drug Average Price by Application (2019-2030) & (USD/Dose)
Figure 36. North America Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Biosimilar Drug Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Biosimilar Drug Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Biosimilar Drug Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Biosimilar Drug Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Biosimilar Drug Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Biosimilar Drug Consumption Value Market Share by Region (2019-2030)
Figure 56. China Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Biosimilar Drug Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Biosimilar Drug Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Biosimilar Drug Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Biosimilar Drug Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Biosimilar Drug Market Drivers
Figure 77. Biosimilar Drug Market Restraints
Figure 78. Biosimilar Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Biosimilar Drug in 2023
Figure 81. Manufacturing Process Analysis of Biosimilar Drug
Figure 82. Biosimilar Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Biosimilar Drug Picture
Figure 2. Global Biosimilar Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biosimilar Drug Consumption Value Market Share by Type in 2023
Figure 4. Injection Examples
Figure 5. Tablets Examples
Figure 6. Other Types Examples
Figure 7. Global Biosimilar Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Biosimilar Drug Consumption Value Market Share by Application in 2023
Figure 9. Ankylosing Spondylitis Examples
Figure 10. Tumor Examples
Figure 11. Rheumatoid Arthrtis Examples
Figure 12. Cardiovascular Examples
Figure 13. Other Application Examples
Figure 14. Global Biosimilar Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Biosimilar Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Biosimilar Drug Sales Quantity (2019-2030) & (K Dose)
Figure 17. Global Biosimilar Drug Average Price (2019-2030) & (USD/Dose)
Figure 18. Global Biosimilar Drug Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Biosimilar Drug Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Biosimilar Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Biosimilar Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Biosimilar Drug Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Biosimilar Drug Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Biosimilar Drug Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Biosimilar Drug Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Biosimilar Drug Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Biosimilar Drug Average Price by Type (2019-2030) & (USD/Dose)
Figure 33. Global Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Biosimilar Drug Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Biosimilar Drug Average Price by Application (2019-2030) & (USD/Dose)
Figure 36. North America Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Biosimilar Drug Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Biosimilar Drug Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Biosimilar Drug Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Biosimilar Drug Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Biosimilar Drug Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Biosimilar Drug Consumption Value Market Share by Region (2019-2030)
Figure 56. China Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Biosimilar Drug Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Biosimilar Drug Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Biosimilar Drug Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Biosimilar Drug Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Biosimilar Drug Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Biosimilar Drug Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Biosimilar Drug Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Biosimilar Drug Market Drivers
Figure 77. Biosimilar Drug Market Restraints
Figure 78. Biosimilar Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Biosimilar Drug in 2023
Figure 81. Manufacturing Process Analysis of Biosimilar Drug
Figure 82. Biosimilar Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
